Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Kit for detecting four psychiatric drugs and metabolites thereof in vivo

The technology of a kit and a detection body is applied in the field of kits for detecting four kinds of psychiatric drugs and their metabolites in the body, which can solve the problems of expensive isotope internal standard consumables, unable to fully realize the chromatographic separation of drugs, and prone to interference.

Pending Publication Date: 2022-01-11
SHANGHAI MENTAL HEALTH CENT (SHANGHAI PSYCHOLOGICAL COUNSELLING TRAINING CENT)
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because clinical patients often take a variety of drugs for basic mental diseases at the same time, the chromatographic separation of drugs is often not fully realized by the high performance liquid chromatography ultraviolet detection method, which is prone to interference and affects the quantitative results; the high performance liquid chromatography tandem mass spectrometry As a detection method, it is a powerful analysis and detection tool that integrates the high separation ability of high performance liquid chromatography, high sensitivity and high selectivity of mass spectrometer. Although mass spectrometry can be used as a detection method, it can be accurately quantified, but on the one hand, the equipment is expensive. On the other hand, isotope internal standard consumables are also very expensive and environmentally unfriendly

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit for detecting four psychiatric drugs and metabolites thereof in vivo
  • Kit for detecting four psychiatric drugs and metabolites thereof in vivo
  • Kit for detecting four psychiatric drugs and metabolites thereof in vivo

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Example 1: A kit for simultaneously separating aripiprazole, dehydroariprazole, chlorpromazine, and quetiapine

[0044] A kit for detecting four psychiatric drugs and their metabolites in serum, including:

[0045] (1) Mixed standard substance solution TDM detection tube, its preparation method comprises:

[0046] S1 prepares the internal standard solution as: internal standard-carbamazepine working solution: Accurately weigh 20 mg of carbamazepine standard substance, first dissolve it in a 100 mL volumetric flask with 10 mL of methanol, then dilute to volume with 50% v / v methanol-water solution, Prepare a carbamazepine stock solution with a concentration of 0.2 mg / mL, and then dilute it to 2 μg / mL with 50% v / v methanol-water solution to obtain an internal standard-carbamazepine working solution;

[0047] S2 Preparation of mixed standard solution TDM detection tube: S21 Preparation of mixed standard mother solution: Accurately weigh the appropriate amount of commonly u...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a kit for detecting four psychiatric drugs or metabolites thereof in an in-vivo biological sample, wherein the kit comprises: (1) a mixed standard solution TDM detection tube, of which the preparation method comprises: adding an internal standard solution and a mixed standard solution into the TDM detection tube, and drying the tube; and (2) a sample solution detection TDM detection tube, of which a preparation method comprises the following steps: adding the internal standard solution into the TDM detection tube, and drying the tube; (3) a reconstitution solution being a methanol-water solution containing formic acid; (4) a specification, recording a use method of the kit. The kit is stored at the temperature of -20 to -15 DEG C. Liquid-liquid extraction and an internal standard UPLC-UV method are adopted, and separation of common psychiatric drugs and active metabolites thereof in human serum or hair is achieved; the mobile phase is free of salt additives, so that switching of different methods is facilitated. Therefore, the kit has good clinical detection value and economic significance while the detection time is greatly shortened, and has good application prospects.

Description

technical field [0001] The invention relates to the field of detection of blood concentration of psychiatric drugs, in particular to a kit for detecting four psychiatric drugs and their metabolites in vivo. Background technique [0002] Antipsychotic drugs, also known as strong tranquilizers or neuroleptics, are a group of drugs used to treat schizophrenia and other psychotic disorders. The usual therapeutic dose does not affect the patient's intelligence and consciousness, but it can effectively control the patient's psychomotor excitement, hallucinations, delusions, hostility, thinking disorders and abnormal behaviors and other mental symptoms. Patients usually have sleep disorders and often take sedative and tranquillizing drugs at the same time. However, in order to monitor the blood concentration of therapeutic drugs in patients, at least these drugs need to be separated to avoid interference. [0003] Aripiprazole is used in the treatment of various forms of schizophr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N30/02G01N30/06G01N30/14G01N30/30G01N30/32G01N30/34G01N30/74
CPCG01N30/02G01N30/06G01N30/14G01N30/30G01N30/32G01N30/34G01N30/74G01N2030/324
Inventor 孙秀佳张晨李华芳
Owner SHANGHAI MENTAL HEALTH CENT (SHANGHAI PSYCHOLOGICAL COUNSELLING TRAINING CENT)
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products